InsiderTrades

Form 4 for PFE Pfizer

Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001225208-24-003049 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-27 2024-02-23 PFE BOURLA ALBERT COB, CEO, Dir F - Tax $27.40 -112.0K 327.7K -25% -$3.07M
D 2024-02-27 2024-02-23 PFE BOURLA ALBERT COB, CEO, Dir M - OptEx $27.34 +127.7K 439.7K +41% +$3.49M
D 2024-02-27 2024-02-23 PFE BOURLA ALBERT COB, CEO, Dir M - OptEx $0.00 -127.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-23 F D 8,831 $27.76 430,917 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
2 Common Common Stock 2024-02-23 M A 127,674 $27.34 439,748 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
3 Common Common Stock 2024-02-23 F D 103,178 $27.37 327,739 D — — (F3) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F4) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
4 Derivative Stock Appreciation Rights 2024-02-23 M D 127,674 $0.00 0 D $27.34 · 2024-02-23 to 2024-02-23 127,674 Common Stock